Be part of the knowledge.™

Oncology and Hematology

2100

LikeLikedUnlike

Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
Project Oncology®
Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
- Ryan Quigley
  Peer
Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
Project Oncology®
Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
- Ryan Quigley
  Peer
The Future of Immunotherapy: Advancing Care in Endometrial Cancer
Project Oncology®
The Future of Immunotherapy: Advancing Care in Endometrial Cancer
- Casey Cosgrove, MD
  Peer
CLL17 Trial Insights: Fixed-Duration vs Continuous Therapy in Frontline CLL
Project Oncology®
CLL17 Trial Insights: Fixed-Duration vs Continuous Therapy in Frontline CLL
- Ryan Quigley
  Peer
Dexamethasone Timing and Infusion Reactions in HER2+ Breast Cancer
Project Oncology®
Dexamethasone Timing and Infusion Reactions in HER2+ Breast Cancer
Early Adulthood Weight Gain Linked to Breast Tissue Complexity Changes
Project Oncology®
Early Adulthood Weight Gain Linked to Breast Tissue Complexity Changes
advertisement

Q-Challenge™
Advancing Prostate Cancer Care: Integrating Guideline Updates and Patient Prefe…
4 questions
Q-Challenge™
BTK-Based Approach for Managing CLL/SLL
3 questions
Q-Challenge™
Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
4 questions
Q-Challenge™
HER2-Targeted ADCs in Advanced NSCLC
2 questions
Q-Challenge™
Unresectable Hepatocellular Carcinoma: Selecting the Optimal First-Line ICI Com…
10 questions
Q-Challenge™
A Personalized Approach to Perioperative Immunotherapy in Early-Stage Resectabl…
4 questions
advertisement

Operational Considerations for Bispecific T-Cell Engager Therapies
Medical Industry Feature
Operational Considerations for Bispecific T-Cell Engager Therapies
- Jennifer Caudle, DO
  Peer
- David M. Waterhouse, MD, MPH
  Peer
New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Medical Industry Feature
New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
- Brian Gill, M.D.
  Peer
Investigator Perspectives on Treating Patients in a Ph2 NSCLC Trial
Project Oncology®
Investigator Perspectives on Treating Patients in a Ph2 NSCLC Trial
- Jennifer Caudle, DO
  Peer
- Ross Camidge, MD, PhD
  Peer
- Jonathan Goldman, MD
  Peer
Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Medical Industry Feature
Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
- Joel Gabre, M.D, MPH
  Peer
Managing Capillary Leak Syndrome: Early Recognition and Intervention in BPDCN Care
Medical Industry Feature
Managing Capillary Leak Syndrome: Early Recognition and Intervention in BPDCN Care
- Jennifer Caudle, DO
  Peer
- James McCloskey II, MD
  Peer
Advancing Care in Pretreated HR+/HER2- mBC
Medical Industry Feature
Advancing Care in Pretreated HR+/HER2- mBC
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Aashini Master, DO
  Peer
- Neil M. Iyengar, MD
  Peer

Medical News
Advancing Bladder Cancer Care: BRAVO Study on Surveillance Technologies and Cos…
12/10/2025
Medical News
Comparative Analysis of Pirtobrutinib vs. Ibrutinib for CLL and SLL Treatment
12/10/2025
Medical News
AI-Driven Transformations in Colon Cancer Pathology
12/10/2025
Medical News
Evaluating AI in Prostate MRI: Performance and Clinical Implications
12/10/2025
Medical News
FDA Regulatory Moves and Their Impact on Urologic Therapeautics: A Case of Deta…
12/10/2025
Medical News
Combined Ianalumab and Eltrombopag Therapy in Immune Thrombocytopenia: Insights…
12/10/2025

Program Chapters

Segment Chapters

Playlist:

Recommended